Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive a less toxic treatment than the ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments in ...

Share on Pinterest Scientists are studying the link between B cells and autoimmune diseases. Luis Alvarez/Getty Images The immune system prevents the production of antibodies that attack and damage ...

Our body's immune system is quick to spring into action when it spots a foreign object that shouldn't be there. Sometimes the same defense mechanism can get confused and end up attacking the very ...

Monoclonal B-cell lymphocytosis is when your body produces an elevated number of identical B cells. In some cases, it can develop into chronic lymphocytic leukemia. Monoclonal B-cell lymphocytosis ...

B-PLL is a rare subtype that’s more aggressive than other blood cancers and has a low survival rate. However, ongoing research and clinical trials may offer new treatment options to improve outcomes.

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

There's a new frontier in treating autoimmune diseases.